Profibrogenic Gremlin-1 expression in prostate cancer and the clinicopathologic association.

Ren D, Chien YH, Xu R, Tsung KY, Ayala GE, Ko TC, Cao Y, Wang R, Shu T

Open source

DOI
10.3389/fonc.2026.1910229
Published
2026
Container
Frontiers in oncology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2026.1910229,
  title = {Profibrogenic Gremlin-1 expression in prostate cancer and the clinicopathologic association.},
  author = {Ren D and Chien YH and Xu R and Tsung KY and Ayala GE and Ko TC and Cao Y and Wang R and Shu T},
  year = {2026},
  journal = {Frontiers in oncology},
  doi = {10.3389/fonc.2026.1910229},
  url = {https://doi.org/10.3389/fonc.2026.1910229}
}

RIS

TY  - JOUR
TI  - Profibrogenic Gremlin-1 expression in prostate cancer and the clinicopathologic association.
AU  - Ren D
AU  - Chien YH
AU  - Xu R
AU  - Tsung KY
AU  - Ayala GE
AU  - Ko TC
AU  - Cao Y
AU  - Wang R
AU  - Shu T
PY  - 2026
JO  - Frontiers in oncology
DO  - 10.3389/fonc.2026.1910229
UR  - https://doi.org/10.3389/fonc.2026.1910229
ER  - 

APA

D, R., YH, C., R, X., KY, T., GE, A., TC, K., Y, C., R, W., & T, S. (2026). Profibrogenic Gremlin-1 expression in prostate cancer and the clinicopathologic association.. Frontiers in oncology. https://doi.org/10.3389/fonc.2026.1910229

Source records